)
Sutro Biopharma (STRO) investor relations material
Sutro Biopharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of three Class II directors: Jane Chung, Connie Matsui, and James Panek, with board recommending a vote for all nominees.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026, recommended for approval.
Advisory vote to approve compensation of named executive officers, with board recommending approval.
Board of directors and corporate governance
Board is seeking shareholder approval for the election of three Class II directors at the 2026 annual meeting.
Executive compensation and say-on-pay
Advisory vote on executive compensation is included, allowing shareholders to express approval or disapproval of named executive officer pay.
- Virtual meeting to elect directors, ratify auditor, and approve executive pay, with focus on governance.STRO
Proxy filing23 Apr 2026 - Next-gen ADCs advance with robust pipeline, dual-payload innovation, and strong clinical progress.STRO
Corporate presentation23 Apr 2026 - Next-generation ADCs advance toward key milestones, targeting major oncology markets with strong data.STRO
Corporate presentation24 Mar 2026 - Up to $300M in securities registered, including $100M ATM equity via TD Cowen for broad corporate use.STRO
Registration filing23 Mar 2026 - Revenue up 65% to $102.5M, net loss narrowed, and cash runway extended into 2028.STRO
Q4 202523 Mar 2026 - Accelerated ADC pipeline advances with key clinical data and INDs expected in the next year.STRO
The Citizens Life Sciences Conference 202610 Mar 2026 - Transformed leadership and advanced ADC pipeline drive clinical progress, with key data due mid-year.STRO
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - Accelerated ADC pipeline and platform innovation drive clinical progress and strategic growth.STRO
44th Annual J.P. Morgan Healthcare Conference3 Feb 2026 - Luvelta's pivotal trials and platform innovation target broader patient access and industry leadership.STRO
2024 Wells Fargo Healthcare Conference22 Jan 2026
Next Sutro Biopharma earnings date
Next Sutro Biopharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage